Multicomponent LC-MS/MS screening method for detection of new psychoactive drugs, legal highs, in urine-Experience from the Swedish population

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 930, Issue , 2013, Pages 112-120

  Al Saffar, Yasir ^a   Stephanson, Niclas Nikolai ^a   Beck, Olof ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Internet drugs; Legal highs; Liquid chromatography; Mass spectrometry; Screening; Urine

Indexed keywords

CHROMATOGRAPHIC SYSTEMS; CLINICAL TOXICOLOGIES; ELECTROSPRAY INTERFACES; INTERNAL STANDARDS; LEGAL HIGHS; METHOD VALIDATIONS; SELECTED REACTION MONITORING; URINE;

DRUG PRODUCTS; ETHYLENE; INTERNET; LABORATORIES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; ORGANIC SOLVENTS; SCREENING;

BODY FLUIDS;

3 FLUOROMETHCATHINONE; 4 FLUOROAMPHETAMINE; 4 FLUOROMETHCATHINONE; 4 HYDROXY N METHYL N ETHYLTRYPTAMINE; 4 METHOXYMETHCATHINONE; 4 METHYLMETHCATHINONE; 5,6 METHYLENEDIOXY 2 AMINOINDANE; ALPHA METHYLAMINO BUTYROPHENONE; DEOXYPIPRADOL; DRUG METABOLITE; FORMIC ACID; METHOXETAMINE; METHYLENEDIOXYPYROVALERONE; MITRAGYNINE; PETHIDINE; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; DRUG SCREENING; ELECTROSPRAY; ELUTION; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; STORAGE; SWEDEN; TANDEM MASS SPECTROMETRY; URINALYSIS; URINE;

CHROMATOGRAPHY, LIQUID; DESIGNER DRUGS; HUMANS; PSYCHOTROPIC DRUGS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SWEDEN; TANDEM MASS SPECTROMETRY;

EID: 84878858370     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2013.04.043     Document Type: Article

References (53)

1. Henderson G.L. J. Forensic Sci. 1988, 33:569.
2. Ruttenber A.J. J. Addict. Dis. 1991, 11:71.
3. Jerrard D.A. J. Emerg. Med. 1990, 8:733.
4. http://www.emcdda.europa.eu/.
5. Carroll F.I., Lewin A.H., Mascarella S.W., Seltzman H.H., Reddy P.A. Ann. N.Y. Acad. Sci. 2012, 1248:18.
6. Bell C., George C., Kicman A.T., Traynor A. Drug Test. Anal. 2011, 3:496.
7. Thörngren J.-O., Östervall F., Garle M. J. Mass Spectrom. 2008, 43:980.
8. Pitt J.J. Clin. Biochem. Rev. 2009, 30:19.
9. Lee H.K., Ho C.S., Iu Y.P.H., Lai P.S.J., Shek C.C., Lo Y.-C., Klinke H.B., Wood M. Anal. Chim. Acta 2009, 649:80.
10. Maurer H.H. Ther. Drug Monit. 2010, 32:324. doi: 10.1097/FTD.31811090b1013dca1295.
11. Peters F.T. Clin. Biochem. 2011, 44:54.
12. Ojanperä I., Kolmonen M., Pelander A. Anal. Bioanal. Chem. 2012, 403:1203.
13. Nordgren H.K., Beck O. Ther. Drug Monit. 2004, 26:90.
14. Eichhorst J.C., Etter M.L., Rousseaux N., Lehotay D.C. Clin. Biochem. 2009, 42:1531.
15. Bjornstad K., Beck O., Helander A. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2009, 877:1162.
16. Maralikova B., Weinmann W. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2004, 811:21.
17. European Union Decision 2002/657/EC 2013, Available in http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L: 2002:221:0008:0036:ES:PDF.
18. U.S. Department of Health and Human Services, Food and Drug Administration (FDA).Center for Veterinary Medicine Guidance for Industry. Mass Spectrometry for Confirmation of the Identity of Animal Drug Residues (FDA Guidance Document 118) 2003, Available in http://www.fda.gov/cvm/Guidance/guide118.pdf.
19. World Anti-Doping Agency WADA-Technical Document-TD2003IDCR 2013, Available in http://www.wada-ama.org/rtecontent/document/criteria 1 2.pdf.
20. Philipp A.A., Wissenbach D.K., Weber A.A., Zapp J., Maurer H.H. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2011, 879:1049.
21. Strano-Rossi S., Anzillotti L., Castrignano E., Romolo F.S., Chiarotti M. J. Chromatogr. A 2012, 1258:37.
22. Wohlfarth A., Weinmann W., Dresen S. Anal. Bioanal. Chem. 2010, 396:2403.
23. Peters F.T., Schaefer S., Staack R.F., Kraemer T., Maurer H.H. J. Mass Spectrom. 2003, 38:659.
24. Tsutsumi H., Katagi M., Miki A., Shima N., Kamata T., Nishikawa M., Nakajima K., Tsuchihashi H. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2005, 819:315.
25. Spiller H.A., Ryan M.L., Weston R.G., Jansen J. Clin. Toxicol. (Phila.) 2011, 49:499.
26. Macher A.M., Penders T.M. Drug Test. Anal. 2012, 5:130.
27. Krasowski M.D., Pizon A.F., Siam M.G., Giannoutsos S., Iyer M., Ekins S. BMC Emerg. Med. 2009, 9:5.
28. Tsujikawa K., Mikuma T., Kuwayama K., Miyaguchi H., Kanamori T., Iwata Y.T., Inoue H. Forensic Sci. Int. 2012, 220:103.
29. Tsujikawa K., Kuwayama K., Miyaguchi H., Kanamori T., Iwata Y.T., Inoue H. Forensic Sci. Int. 2009, 193:106.
30. Saleh A., Stephanson N.N., Granelli I., Villén T., Beck O. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2012, 909:6.
31. Helander A., Kenan N., Beck O. Rapid Commun. Mass Spectrom. 2010, 24:1737.
32. Arndt T., Claussen U., Gussregen B., Schrofel S., Sturzer B., Werle A., Wolf G. Forensic Sci. Int. 2011, 208:47.
33. Kronstrand R R., Roman M M., Thelander G G., Eriksson A A. J. Anal. Toxicol. 2011, 35:242.
34. Fass J.A., Fass A.D., Garcia A.S. Ann. Pharmacother. 2012, 46:436.
35. Prosser J.M., Nelson L.S. J. Med. Toxicol. 2012, 8:33.
36. Thornton S.L., Gerona R.R., Tomaszewski C.A. J. Med. Toxicol. 2012, 8:310.
37. Lindeman E., Hultén P., Ström S., Enlund M., Al-Saffar Y., Helander A. Läkartidningen 2012, 109:1954.
38. Misselbrook G.P., Hamilton E.J. Acute Med. 2012, 11:157.
39. Hofer K.E., Grager B., Muller D.M., Rauber-Luthy C., Kupferschmidt H., Rentsch K.M., Ceschi A. Ann. Emerg. Med. 2012, 60:97.
40. Shields J.E., Dargan P.I., Wood D.M., Puchnarewicz M., Davies S., Waring W.S. Clin. Toxicol. (Phila.) 2012, 50:438.
41. Schifano F., Corkery J., Ghodse A.H. J. Clin. Psychopharmacol. 2012, 32:710.
42. Gustavsson D., Escher C. Lakartidningen 2009, 106:2769.
43. Wikstrom M., Thelander G., Nystrom I., Kronstrand R. J. Anal. Toxicol. 2010, 34:594.
44. Carvalho M., Carmo H., Costa V.M., Capela J.P., Pontes H., Remiao F., Carvalho F., Bastos Mde L. Arch. Toxicol. 2012, 86:1167.
45. Wood D.M., Dargan P.I. Clin. Toxicol. (Phila.) 2012, 50:727.
46. Corkery J.M., Elliott S., Schifano F., Corazza O., Ghodse A.H. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 39:253.
47. Simmler L.D., Buser T.A., Donzelli M., Schramm Y., Dieu L.H., Huwyler J., Chaboz S., Hoener M.C., Liechti M.E. Br. J. Pharmacol. 2013, 168:458.
48. Zuba D., Adamowicz P., Byrska B. Forensic Sci. Int. 2013, 227:15.
49. Maheux C.R., Copeland C.R. Drug Test. Anal. 2012, 4:17.
50. EMCDDA EMCDDA 2011.
51. Gallagher C.T., Assi S., Stair J.L., Fergus S., Corazza O., Corkery J.M., Schifano F. Hum. Psychopharmacol. 2012, 27:106.
52. Taljemark J., Johansson B.A. Eur. Child Adolesc. Psychiatry 2012, 21:527.
53. Kjellgren A., Soussan C. J. Psychoactive Drugs 2011, 43:211.